Alle Angaben unseres Internetangebotes wurden sorgfältig geprüft. Wir bemühen uns, dieses Informationsangebot stetig zu erweitern und zu aktualisieren. Eine Garantie für die Vollständigkeit, ...
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and ...
Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma Recommendation based on IMROZ phase 3 study demonstrating Sarclisa in ...
A booster to transform breakthrough technologies and processes developed by best-in-class academic partners and start-ups into innovative solutions to accelerate our R&D portfolio. In 2022, the ...
Third quarter 2024 results were reviewed by management during a conference call with the financial community on Friday October 25, 2024. The presentation was followed by a Q&A session. We’re proud to ...
Sanofi US (Sanofi-Aventis U.S. LLC and Sanofi US Services Inc.) respects the interest that visitors to our websites have in understanding what information is collected electronically, how it is ...
Our manufacturing sites are state-of-the-art, powered by big data and digital. It is by producing vaccines that our mission takes on its full meaning. It is the bridge between scientific advances and ...
We want to improve the lives of millions of people who don’t have access to the help they need. To do that, we’re expanding our health-system partnerships at local, regional, and global levels.
A Million Conversations is Sanofi’s global initiative to rebuild trust in healthcare with the underrepresented. Specifically with Black and ethnic minority groups, women, people with disabilities, and ...
Auswurf, Husten, Atemnot - obwohl die chronisch obstruktive Lungenerkrankung weit verbreitet ist, haben sich die Therapien seit mehr als einem Jahrzehnt nicht wesentlich weiterentwickelt. Wo steht die ...
We care for the planet by minimizing the environmental impacts of our products and activities while strengthening our business resilience in the face of environmental changes. At Sanofi, our ...